Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pegasys immunology sub-study in HBeAg-negative CHB
NCT01237496Phase 3Completed
- Sponsor
- Roche
- Start
- Jul 2005
- Primary completion
- Sep 2009
- Modality
- Cytokines & Interferons
- Countries
- 1
01
Overview
A Phase 3 trial of pegylated interferon alpha in Chronic Hepatitis B (CHB), sponsored by Roche. Started Jul 2005; status: completed.
02
Drugs
pegylated interferon alpha
03
Conditions
Chronic Hepatitis B (CHB)
Beyond the preview
Go deeper on NCT01237496.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01237496.